{"id":801,"date":"2018-06-01T17:12:12","date_gmt":"2018-06-01T15:12:12","guid":{"rendered":"http:\/\/www.olym.nl\/?p=801\/"},"modified":"2019-01-14T17:13:42","modified_gmt":"2019-01-14T16:13:42","slug":"series-a-financing-round-varmx","status":"publish","type":"post","link":"https:\/\/www.olym.nl\/en\/2018\/801\/","title":{"rendered":"Series A Financing Round VarmX"},"content":{"rendered":"<p>VarmX, the Leiden based biotech company focusing on the development of therapies in the field of hemostasis and thrombosis, has closed a series A financing round of \u20ac 7.5 million. The round was led by the existing shareholder BioGeneration Ventures (BGV) and regional economic development company InnovationQuarter (IQ) also invested. Uniiq also became shareholder through conversion of its start-up loan to the company. The equity financing is supplemented by the Netherlands Enterprise Agency (RVO.nl) with an innovation credit of \u20ac 5.0 million supplementing the financing to a total of \u20ac 12.5 million. The series A round is a follow up to the initial seed financing in June 2017 by BGV and IQ. We advised BGV and IQ.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>VarmX, the Leiden based biotech company focusing on the development of therapies in the field of hemostasis and thrombosis, has closed a series A financing round of \u20ac 7.5 million. The round was led by the existing shareholder BioGeneration Ventures (BGV) and regional economic development company InnovationQuarter (IQ) also invested. Uniiq also became shareholder through &hellip; <a href=\"https:\/\/www.olym.nl\/en\/2018\/801\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Series A Financing Round VarmX<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":773,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27,30,32,36],"tags":[],"class_list":["post-801","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lawyers","category-marcel-van-de-vorst-en","category-track-record-en","category-venture-capital-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/posts\/801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/comments?post=801"}],"version-history":[{"count":1,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/posts\/801\/revisions"}],"predecessor-version":[{"id":802,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/posts\/801\/revisions\/802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/media\/773"}],"wp:attachment":[{"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/media?parent=801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/categories?post=801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olym.nl\/en\/wp-json\/wp\/v2\/tags?post=801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}